COO · The Cooper Companies, Inc.
$70.172026-05-17Sector: Healthcare; Industry: Medical - Instruments & Supplies; Sub-Industry: Health Care Supplies
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$11
-84.3% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($12 · $6) Analysts Range ($73 · $100) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2022.Q1 | $2.9B | — | 17.3% | 0.0% | $1.0B | $128MM | $1.1B | 7.8% | — | 10.1% | $9.9B | $14.97 | — |
| 2023.Q1 | $3.3B | 13.2% | 15.3% | 21.1% | $401MM | −$1.7B | −$1.3B | 8.3% | — | 4.0% | $9.9B | $1.96 | — |
| 2024.Q1 | $3.6B | 8.6% | 14.8% | 29.2% | $377MM | −$370MM | $8MM | 8.1% | — | 3.7% | $10.3B | $1.50 | — |
| 2025.Q1 | $3.9B | 8.4% | 18.1% | 32.5% | $476MM | −$666MM | −$190MM | 9.2% | — | 4.6% | $10.6B | $1.99 | — |
| 2026.Q1 | $4.2B | 6.6% | 17.2% | 33.7% | $473MM | −$239MM | $234MM | 8.8% | — | 4.4% | $10.7B | $2.04 | 19.3 |
| italics below = DCF projection · 10yr Rev CAGR: 4.6% |
| 2027.Q1 | $4.4B | +5.5% | 16.7% | 32.3% | $495MM | −$597MM | −$102MM | 8.8% | −$94MM | 4.5% | $11.3B | $2.52 | 27.8 |
| 2028.Q1 | $4.6B | +5.2% | 17.3% | 31.0% | $550MM | −$617MM | −$66MM | 8.8% | −$56MM | 4.7% | $12.0B | $2.80 | 25.1 |
| 2029.Q1 | $4.9B | +5.3% | 18.0% | 29.6% | $615MM | −$675MM | −$60MM | 8.8% | −$47MM | 5.0% | $12.6B | $3.13 | 22.4 |
| 2030.Q1 | $5.1B | +4.7% | 18.0% | 28.2% | $657MM | −$636MM | $21MM | 8.7% | $15MM | 5.1% | $13.3B | $3.34 | 21.0 |
| 2031.Q1 | $5.3B | +4.4% | 18.0% | 26.9% | $699MM | −$644MM | $55MM | 8.7% | $36MM | 5.1% | $13.9B | $3.55 | 19.8 |
|
| Term. Yr+ | $6.8B | 4.1% | 16.6% | 20.0% | $903MM | −$430MM | $472MM | 8.6% | $4.6B | 8.6% | — | — | — |
Active scenario IV: $11 (-84.3% vs market)